What is Credentis?
Credentis, a Swiss enterprise, is at the forefront of biomimetic dental science, developing and offering innovative oral care solutions. Its patented Curodont product line, designed for dental professionals, targets the treatment and management of early-stage dental issues like caries, erosion, and sensitivity through advanced peptide-based technology. Complementing its professional offerings, Credentis also provides a consumer range of daily oral care products focused on enamel remineralization and protection. The company's commitment to non-invasive dental care is a key differentiator, merging cutting-edge research with Swiss precision.
How much funding has Credentis raised?
Credentis has raised a total of $1.7M across 1 funding round:
Series B
$1.7M
Series B (2013): $1.7M with participation from Aargauische Kantonalbank and StartAngels Network
Key Investors in Credentis
Aargauische Kantonalbank
Aargauische Kantonalbank is a prominent financial service provider in Switzerland, offering a comprehensive suite of banking and investment solutions to private clients, SMEs, and corporations. Their involvement suggests a strategic financial partnership aimed at supporting Credentis's growth trajectory.
StartAngels Network
StartAngels Network is a Swiss-based platform connecting business angel investors with early-stage companies. Their participation highlights Credentis's appeal to early-stage investment and the network's role in fostering innovation through capital and expertise.
What's next for Credentis?
The substantial enterprise-level funding and recent strategic investment indicate Credentis is poised for significant scaling and market expansion. This capital infusion is likely to accelerate product development, enhance manufacturing capabilities, and broaden its market reach, both within the professional dental community and the consumer sector. The company's focus on non-invasive, peptide-based solutions aligns with growing global trends towards preventative and sustainable healthcare, positioning Credentis for sustained growth and leadership in the advanced oral care market.
See full Credentis company page
